Friday, September 14, 2012

Health - Google News: Cornerstone says FDA panel votes against drug - Businessweek

Health - Google News
Google News
Cornerstone says FDA panel votes against drug - Businessweek
Sep 13th 2012, 19:30


Cornerstone says FDA panel votes against drug
Businessweek
NEW YORK (AP) — Shares of Cornerstone Therapeutics Inc. dropped Thursday after the company said a regulatory panel said the Food and Drug Administration should not approve Cornerstone's drug lixivaptan. Cornerstone said the FDA's cardiovascular and ...
FDA Panel Rejects Lixivaptan for CHFMedPage Today
Cornerstone Falls After US Panel Rejects Low-Salt DrugBloomberg
FDA Panel Votes Against Approval of Hyponatremia DrugFamily Practice News Digital Network
Reuters -MedReps
all 30 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More